Germany
· Delayed Price · Currency is EUR CSPC Pharmaceutical Group Statistics
Total Valuation
FRA:CVG has a market cap or net worth of EUR 10.03 billion. The enterprise value is 9.18 billion.
| Market Cap | 10.03B |
| Enterprise Value | 9.18B |
Important Dates
The last earnings date was Friday, May 23, 2025.
| Earnings Date | May 23, 2025 |
| Ex-Dividend Date | Oct 31, 2024 |
Share Statistics
| Current Share Class | 11.43B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.85% |
| Shares Change (QoQ) | -1.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 7.82B |
Valuation Ratios
The trailing PE ratio is 18.75 and the forward PE ratio is 15.90.
| PE Ratio | 18.75 |
| Forward PE | 15.90 |
| PS Ratio | 2.91 |
| PB Ratio | 2.32 |
| P/TBV Ratio | 2.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 17.17 |
| EV / Sales | 2.83 |
| EV / EBITDA | 12.56 |
| EV / EBIT | 15.94 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | n/a |
| Interest Coverage | 109.38 |
Financial Efficiency
Return on equity (ROE) is 12.21% and return on invested capital (ROIC) is 8.64%.
| Return on Equity (ROE) | 12.21% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 8.64% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 161,109 |
| Profits Per Employee | 24,982 |
| Employee Count | 21,400 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.62% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -6.62% |
| 50-Day Moving Average | 0.66 |
| 200-Day Moving Average | 0.62 |
| Relative Strength Index (RSI) | 72.23 |
| Average Volume (20 Days) | 2,912 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:CVG had revenue of EUR 3.45 billion and earned 534.62 million in profits. Earnings per share was 0.05.
| Revenue | 3.45B |
| Gross Profit | 2.36B |
| Operating Income | 617.93M |
| Pretax Income | 677.85M |
| Net Income | 534.62M |
| EBITDA | 761.58M |
| EBIT | 617.93M |
| Earnings Per Share (EPS) | 0.05 |
Balance Sheet
The company has 1.17 billion in cash and 64.68 million in debt, giving a net cash position of 1.10 billion.
| Cash & Cash Equivalents | 1.17B |
| Total Debt | 64.68M |
| Net Cash | 1.10B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.32B |
| Book Value Per Share | 0.36 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 68.45%, with operating and profit margins of 17.92% and 15.51%.
| Gross Margin | 68.45% |
| Operating Margin | 17.92% |
| Pretax Margin | 19.66% |
| Profit Margin | 15.51% |
| EBITDA Margin | 22.09% |
| EBIT Margin | 17.92% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 4.88%.
| Dividend Per Share | 0.04 |
| Dividend Yield | 4.88% |
| Dividend Growth (YoY) | 19.27% |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | 1.85% |
| Shareholder Yield | 6.72% |
| Earnings Yield | 5.33% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 15, 2020. It was a forward split with a ratio of 1.6.
| Last Split Date | Oct 15, 2020 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |